Revised SPCs: Jardiance (empagliflozin) film-coated tablets – all strengths

SPCs updated to advise co-treatment with known inducers of uridine 5'-diphosphoglucuronosyltransferase (e.g. rifampicin or phenytoin) is not recommended due to potential risk of decreased efficacy of empagliflozin.

Source:

electronic Medicines compendium